RNA Therapy
RNA therapy is a broad category of medicines that act on RNA, the message layer between DNA and protein. RNA therapies can include ASOs, siRNA, mRNA, splice-modifying therapies, and other approaches. Some reduce a harmful message, some replace a missing instruction temporarily, and others change how RNA is spliced. RNA therapies often differ from gene therapy because they may not permanently change DNA and may require repeat dosing.
Why it matters
Many rare diseases may be reachable through RNA even when DNA editing or gene replacement is difficult. Families should understand the difference between changing a message and changing the underlying gene.
Related content
What Is ASO Therapy?
ASO therapy uses short pieces of synthetic genetic material to change how RNA is read, processed, or reduced inside cells.
What AI Drug Discovery Could Mean for Rare Disease Families
AI drug discovery is entering a new phase: not just better software, but a new industrial stack linking frontier models, pharma data, robotics, and real experiments.
Why it matters: Rare disease research often starts with small datasets, limited funding, urgent timelines, and difficult trial design. AI-linked discovery systems could help researchers generate stronger candidates and better experiments faster, but families should watch for clinical validation, access, manufacturing, and clear evidence rather than hype.
Source: GENEration Hope editorial analysis